Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 8, 2010
Prognostic factors for survival in patients with recurrent cervical cancer previously treated with radiotherapySeiji Mabuchi, Fumiaki Isohashi, Yasuo Yoshioka, et al.
Oncotarget|September 15, 2017
Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature reviewKatsumi Kozasa, Seiji Mabuchi, Naoko Komura, et al.
Plos One|March 18, 2016
Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the OvaryRyoko Takahashi, Seiji Mabuchi, Mahiru Kawano, et al.
Endocrinology|December 26, 2001
Regulation of the PRL promoter by Akt through cAMP response element binding proteinJun Hayakawa, Masahide Ohmichi, Keiichi Tasaka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2019
A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapySeiji Mabuchi, Eriko Yokoi, Kotaro Shimura, et al.
International Journal of Clinical Oncology|May 29, 2017
The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experienceSeiji Mabuchi, Yuri Matsumoto, Naoko Komura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2011
The activity of trabectedin as a single agent or in combination with everolimus for clear cell carcinoma of the ovarySeiji Mabuchi, Takeshi Hisamatsu, Chiaki Kawase, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 15, 2012
Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomySeiji Mabuchi, Mika Okazawa, Yasuto Kinose, et al.
AJOG Global Reports|August 1, 2026
Preoperative prediction of the need for postoperative adjuvant therapy in stage IB cervical cancer using tumor size measured on magnetic resonance imaging and serum squamous cell carcinoma antigen levelsMichihide Maeda, Miho Kitai, Masashi Akada, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 3, 2015
Prognostic Significance of Pretreatment Thrombocytosis in Cervical Cancer Patients Treated With Definitive RadiotherapyMahiru Kawano, Seiji Mabuchi, Yuri Matsumoto, et al.
Pageof 19